Raja Thota
Impact in
- Oncology top 5%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 1
- Surgery 1
- Colorectal and Anal Carcinomas 1
- Cholangiocarcinoma and Gallbladder Cancer Studies 1
- Co-authors
- Andrew D. Racine (2 shared papers)Stan Reissman (2 shared papers)Benjamin A. Gartrell (1 shared paper)Amit Verma (1 shared paper)Kith Pradhan (1 shared paper)Mendel Goldfinger (1 shared paper)Vikas Mehta (1 shared paper)Nitin Ohri (1 shared paper)
- Journals
- Journal of Clinical Oncology (1 paper)Diagnostic Microbiology and Infectious Disease (1 paper)JAMA (1 paper)Cancer Discovery (1 paper)
- Partner nations
- United States
In The Last Decade
Raja Thota
4 papers receiving 546 citations
Raja Thota's Hit Papers
Peers
Comparison fields: 5 of 57
- Oncology 406
- Infectious Diseases 201
- Medical Terminology 1
- Health Information Management 13
- Critical Care and Intensive Care Medicine 12
Countries citing papers authored by Raja Thota
This map shows the geographic impact of Raja Thota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raja Thota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raja Thota more than expected).
Fields of papers citing papers by Raja Thota
This network shows the impact of papers produced by Raja Thota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raja Thota. The network helps show where Raja Thota may publish in the future.
Co-authors
The 25 scholars most cited alongside Raja Thota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System Hit paper breakdown → | 2020 | 523 |
| 2 | 2019 | 27 | |
| 3 | 2022 | 5 | |
| 4 | 2011 | 2 |
About Raja Thota
Raja Thota is a scholar working on Infectious Diseases, Surgery, Critical Care and Intensive Care Medicine, Pathology and Forensic Medicine and General Health Professions, having authored 4 papers that have together received 557 indexed citations. Recurring topics across this work include Nosocomial Infections in ICU (1 paper), COVID-19 Clinical Research Studies (1 paper), Antibiotic Use and Resistance (1 paper), Electronic Health Records Systems (1 paper), COVID-19 and healthcare impacts (1 paper), Genetic factors in colorectal cancer (1 paper), Colorectal and Anal Carcinomas (1 paper) and Cholangiocarcinoma and Gallbladder Cancer Studies (1 paper). The work is most often cited by research in Oncology (406 citations), Infectious Diseases (201 citations), Medical Terminology (1 citation), Health Information Management (13 citations) and Critical Care and Intensive Care Medicine (12 citations). Raja Thota has collaborated with scholars based in United States. Frequent co-authors include Andrew D. Racine, Stan Reissman, Benjamin A. Gartrell, Amit Verma, Kith Pradhan, Mendel Goldfinger, Vikas Mehta, Nitin Ohri, Balázs Halmos and Sanjay Goel. Their work appears in journals such as Journal of Clinical Oncology, Diagnostic Microbiology and Infectious Disease, JAMA and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.